Gabrielle Agin-Liebes, PhD
Instructor of PsychiatryCards
About
Research
Publications
2026
Surrender, disidentification, and reappraisal: a qualitative comparison of psilocybin responders and non-responders in treatment-resistant OCD
Agin-Liebes G, Shnayder S, Fram G, Swift T, Ching T, Jankovsky A, Hokanson J, Pittenger C, Kelmendi B. Surrender, disidentification, and reappraisal: a qualitative comparison of psilocybin responders and non-responders in treatment-resistant OCD. Frontiers In Psychiatry 2026, 17: 1791689. PMID: 42746496, PMCID: PMC13576466, DOI: 10.3389/fpsyt.2026.1791689.Peer-Reviewed Original ResearchThe association between obsessive-compulsive symptoms and self-compassion: A meta-analysis and systematic review
Shnayder S, Funaro M, Ching T, Pittenger C, Kelmendi B, Adams T, Agin-Liebes G. The association between obsessive-compulsive symptoms and self-compassion: A meta-analysis and systematic review. Journal Of Affective Disorders 2026, 405: 121546. PMID: 41796771, DOI: 10.1016/j.jad.2026.121546.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsThis study investigates the link between self-compassion and obsessive-compulsive symptoms, finding that lower self-compassion correlates with higher symptom severity, especially intrusive moral thoughts, suggesting therapeutic potential.
2025
Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis
Ching T, Stahnke B, Shnayder S, Agin-Liebes G, Adams T, Amoroso L, Baiz O, Belser A, Bohner C, Burke M, D’Amico E, DePalmer G, Eilbott J, Fram G, Hokanson J, Jankovsky A, Kichuk S, Martins B, Purohit P, Schaer H, Sierra Y, Witherow C, Pittenger C, Kelmendi B. Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis. Frontiers In Psychiatry 2025, 16: 1726818. PMID: 41450831, PMCID: PMC12728583, DOI: 10.3389/fpsyt.2025.1726818.Peer-Reviewed Original ResearchThis study investigates the effects of single-dose psilocybin on treatment-resistant obsessive-compulsive disorder, finding symptom reductions linked to insights, emotional shifts, and improved psychological flexibility.Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders
Mehtani N, Mian M, Agin-Liebes G, Coker A, Huebner C, Anderson B, Mitchell J. Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders. Journal Of Psychoactive Drugs 2025, ahead-of-print: 1-10. PMID: 41214462, PMCID: PMC12646296, DOI: 10.1080/02791072.2025.2583960.Peer-Reviewed Original ResearchSelf-compassion mediates treatment effects in MDMA-assisted therapy for posttraumatic stress disorder
Agin-Liebes G, Zeifman R, Mitchell J. Self-compassion mediates treatment effects in MDMA-assisted therapy for posttraumatic stress disorder. European Journal Of Psychotraumatology 2025, 16: 2485513. PMID: 40331914, PMCID: PMC12064107, DOI: 10.1080/20008066.2025.2485513.Peer-Reviewed Original ResearchA Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research
Yaden, D. B., Graziosi, M., Owen, A. M., Agin-Liebes, G., Aaronson, S. T., Allen, K. E., ... & Yaden, M. E. (2025). A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research. Psychedelic Medicine, 3(1), 1-18.Peer-Reviewed Original ResearchA Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research
Yaden D, Graziosi M, Owen A, Agin-Liebes G, Aaronson S, Allen K, Barrett F, Bogenschutz M, Carhart-Harris R, Ching T, Cosimano M, Danforth A, Davis A, Garcia-Romeu A, Griffiths R, Grob C, Gründer G, Gukasyan N, Heinzerling K, Hendricks P, Holze F, Horton D, Johnson M, Kelmendi B, Peck S, Koslowski M, Liechti M, Mertens L, Moreno F, Nayak S, Nicholas C, Preller K, Rieser N, Ross S, Sergi K, Smigielski L, Stenbæk D, Vollenweider F, Weiss B, Wolff M, Yaden M. A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research. Psychedelic Medicine 2025, 3: 1-18. PMID: 40351554, PMCID: PMC12060849, DOI: 10.1089/psymed.2024.0019.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsPreliminary results from a community-based ayahuasca-assisted mental health program among a Yaqui Indigenous population in Sonora, Mexico
Giovannetti, C., Loizaga-Velder, A., Campoy Gomez, R., Ochoa Jaime, G. R., Castillo Valenzuela, T., Sanchez, G., ... & Rush, B. (2025). Preliminary results from a community-based ayahuasca-assisted mental health program among a Yaqui Indigenous population in Sonora, Mexico. Journal of Psychedelic Studies.Peer-Reviewed Original ResearchPreliminary results from a community-based ayahuasca-assisted mental health program among a Yaqui Indigenous population in Sonora, Mexico
Giovannetti C, Loizaga-Velder A, Campoy Gomez R, Ochoa Jaime G, Castillo Valenzuela T, Sanchez G, Marcus O, Agin-Liebes G, Rush B. Preliminary results from a community-based ayahuasca-assisted mental health program among a Yaqui Indigenous population in Sonora, Mexico. Journal Of Psychedelic Studies 2025 DOI: 10.1556/2054.2024.00401.Peer-Reviewed Original Research
2024
Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer
Petridis P, Grinband J, Agin-Liebes G, Kinslow C, Zeifman R, Bogenschutz M, Griffiths R, Ross S. Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer. Nature Mental Health 2024, 2: 1408-1414. PMID: 41969367, PMCID: PMC13062533, DOI: 10.1038/s44220-024-00331-0.Peer-Reviewed Original Research
News
News
Get In Touch
Contacts
Locations
Temple Medical Center
Academic Office
40 Temple Street
New Haven, CT 06510